Regretfully, we did not find that patients with stage 4/5 CKD have more CD8+CD28− or CD28+CD57+ cells compared to stage 3 CKD patients; however, because the cohort contains relatively fewer CKD stage 4/5 patients, the comparison might be underpowered. This evidence concerns the gene CD8A and chronic kidney disease.